Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting

Circulation

Volumn 114, Issue SUPPL. 1, 2006, Pages

  Ranasinghe, Aaron M ^a   Quinn, David W ^a   Pagano, Domenico ^a   Edwards, Nicola ^a   Faroqui, Muzzafar ^a   Graham, Timothy R ^a   Keogh, Bruce E ^a   Mascaro, Jorge ^a   Riddington, David W ^a   Rooney, Stephen J ^a   Townend, John N ^a   Wilson, Ian C ^a   Bonser, Robert S ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Glucose; Hemodynamics; Insulin; Myocardial injury; Thyroid; Troponin I

Indexed keywords

GLUCOSE; GLUCOSE INSULIN POTASSIUM; LIOTHYRONINE; MONOCOMPONENT INSULIN; PLACEBO; POTASSIUM; TROPONIN I; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CARDIOPLEGIC AGENT; CARDIOTONIC AGENT; DOPAMINE; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; INSULIN; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEVICE REMOVAL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART INDEX; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; ON PUMP CORONARY ARTERY BYPASS GRAFTING; OPERATION DURATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARDIOPULMONARY BYPASS; DRUG COMBINATION; HEMODYNAMICS; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REPERFUSION INJURY; STATISTICS;

AGED; BIOLOGICAL MARKERS; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS; DOPAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSE; HEMODYNAMIC PROCESSES; HUMANS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; NOREPINEPHRINE; POTASSIUM; PROSPECTIVE STUDIES; TRIIODOTHYRONINE; TROPONIN I; VASOCONSTRICTOR AGENTS;

EID: 33747176601     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.000786     Document Type: Article

References (24)

1. Quinn DW, Pagano D, Bonser RS, Rooney SJ, Graham TR, Wilson IC, Keogh BE, Townend JN, Lewis ME, Nightingale P. Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. The J Thorac Cardiovasc Surg. 2006;131:34.
2. Lazar HL, Chipkin S, Philippides G, Bao Y, Apstein C. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. Ann Thorac Surg. 2000;70:145-150.
3. Lazar HL. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions. J Card Surg. 1994;9:474-478.
4. Doenst T, Richwine RT, Bray MS, Goodwin GW, Frazier OH, Taegtmeyer H. Insulin improves functional and metabolic recovery of reperfused working rat heart. Ann Thorac Surg. 1999;67:1682-1688.
5. Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-1198.
6. Holland FW, Brown PS Jr, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome." Ann Thorac Surg. 1991;52:46-50.
7. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med. 1995;333:1522-1527.
8. Paparella D, Cappabianca G, Visicchio G, Galeone A, Marzovillo A, Gallo N, Memmola C, Schinosa LdLT. Cardiac troponin I release after coronary artery bypass grafting operation: effects on operative and midterm survival. The Ann Thorac Surg. 2005;80:1758-1764.
9. Fellahi JL, Gue X, Richomme X, Monier E, Guillou L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology. 2003;99:270-274.
10. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg. 1996;112:38-51.
11. Christakis GT, Fremes SE, Naylor CD, Chen E, Rao V, Goldman BS. Impact of preoperative risk and perioperative morbidity on ICU stay following coronary bypass surgery. Cardiovasc Surg. 1996;4:29-35.
12. Goodwin GW, Ahmad F, Doenst T, Taegtmeyer H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol Heart Circ Physiol. 1998;274:H1239-H1247.
13. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg. 2003;75:S721-S728.
14. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol. 1993;265:t-7.
15. Ferrara N, Abete P, Corbi G, Paolisso G, Longobardi G, Calabrese C, Cacciatore F, Scarpa D, Iaccarino G, Trimarco B. Insulin-induced changes in [beta]-adrenergic response: An experimental study in the isolated rat papillary muscle. Am J Hypertens. 2005;18:348-353.
16. von Lewinski D, Bruns S, Walther S, Kogler H, Pieske B. Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation. 2005;111:2588-2595.
17. Danzi S, Klein I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid. 2002;12:467-472.
18. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone on the heart. Thyroid. 2002;12:459-466.
19. Schmidt BMW, Martin N, Georgens AC, Tillmann HC, Feuring M, Christ M, Wehling M. Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J Clin Endocrinol Metab. 2002;87:1681-1686.
20. Carr AN, Kranias EG. Thyroid hormone regulation of calcium cycling proteins. Thyroid. 2002;12:453-457.
21. Bahouth SW. Thyroid hormones transcriptionally regulate the beta 1-adrenergic receptor gene in cultured ventricular myocytes. J Biol Chem. 1991;266:15863-15869.
22. Lazar HL, Zhang X, Rivers S, Bernard S, Shemin RJ. Limiting ischemic myocardial damage using glucose-insulin-potassium solutions. Ann Thorac Surg. 1995;60:411-416.
23. Jonassen AK, Aasum E, Riemersma RA, Mjos OD, Larsen TS. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther. 2000;14:615-623.
24. Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, Krieger KH. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 1996;61:1323-1327.